Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Ictero Medical | 2022 | Venture - Series Unknown | Undisclosed | Houston |
| Radial Analytics | 2022 | Seed | Undisclosed | Concord |
| Elucid | 2025 | Series D | $36.5M | Boston |
| inSomaBio | 2025 | Seed | $1.9M | Durham |
| Plastomics | 2025 | Series B | $5.8M | St Louis |
| Ascribe Bioscience | 2025 | Series A | $12.0M | Ithaca |
| Stoke Space | 2025 | Series D | $510.0M | Kent |
| Membrion | 2025 | Series B | $20.0M | Seattle |
| Ares Materials | 2025 | Series B | $12.2M | Plano |
| Ansa Biotechnologies | 2025 | Series B | $45.2M | Emeryville |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 351 | Ictero Medical | Venture - Series Unknown | Undisclosed | Houston, United States |
| 352 | Radial Analytics | Seed | Undisclosed | Concord, United States |
| 353 | Elucid | Series D | $36.5M | Boston, United States |
| 354 | inSomaBio | Seed | $1.9M | Durham, United States |
| 355 | Plastomics | Series B | $5.8M | St Louis, United States |
| 356 | Ascribe Bioscience | Series A | $12.0M | Ithaca, United States |
| 357 | Stoke Space | Series D | $510.0M | Kent, United States |
| 358 | Membrion | Series B | $20.0M | Seattle, United States |
| 359 | Ares Materials | Series B | $12.2M | Plano, United States |
| 360 | Ansa Biotechnologies | Series B | $45.2M | Emeryville, United States |
Ictero Medical is a medical device company that provides minimally invasive gallbladder ablation solutions.
Optimizing patient care transitions with real-time decision support solutions for payers and providers
Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.
InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.
Plastomics develops a new and better way to make the next generation of biotech crops using chloroplast engineering.
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment.
Stoke Space develops fully reusable Nova rockets for orbital space mobility.
Membrion is a manufacturer of ultra-low cost, high performance ion exchange membranes.
AI-enabled optical polymers
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
RadWave Technologies is an early-stage company that focuses on developing advanced technologies for minimally invasive medical procedures.
Liberate Medical licenses a technology that is synchronized with a patient's breathing cycle.
FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture.
XL Batteries develops a technology platform to reduce waste formation.
Nitricity is an energy company that creates renewable nitrogen fertilizer production with zero carbon emissions.
Eyebot develops an eye examination technology to eliminate barriers and provide quality vision care.
RenewCO2 is a research company that develops processes for converting CO2 into polymers and chemicals.
ForCast Orthopedics is a development-stage company that offers treatment for orthopedic infections.
Maui Imaging provides an ultrasound capability that can see into, through, and around bones, metals, plastics, gas, and soft tissue.
TRIC Robotics develops an autonomous, non-chemical pesticide alternative for strawberry farms.
Elementium is a battery materials company that develops and scales novel electrolyte formulations for advanced lithium-ion chemistries.
Inanovate develops a longitudinal assay screening technology for the detection and measurement of multiple proteins.
Empo Health is an in-home health monitoring that fits seamlessly into patients' lives.
Qunnect is a spin-off venture company enabling the quantum internet for quantum repeater operation.
Rubi Laboratories develops biocatalyst solutions that turn carbon emissions into carbon-negative textiles.
National Science Foundation has invested in 2,120 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Science Foundation's top investment sectors include Biotechnology, Health Care, Medical Device, Medical, Renewable Energy. The firm invests across 42 different industry categories.
Among tracked funding rounds, Stoke Space received $510.0M in a Series D round. National Science Foundation's total known invested capital is $6.8B.
National Science Foundation's average investment size is $5.9M across its portfolio of 2,120 companies.
Recent National Science Foundation portfolio additions include Ictero Medical, Radial Analytics, Elucid, inSomaBio, Plastomics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors